• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration.

作者信息

McGready Rose

出版信息

Evid Based Med. 2010 Jun;15(3):71-2. doi: 10.1136/ebm1039.

DOI:10.1136/ebm1039
PMID:20522677
Abstract
摘要

相似文献

1
Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration.在疟疾传播程度中等且对磺胺多辛-乙胺嘧啶高度耐药的地区，用甲氟喹对婴儿进行间歇性预防治疗可降低临床疟疾风险，但安全性和耐受性问题需加以考虑。
Evid Based Med. 2010 Jun;15(3):71-2. doi: 10.1136/ebm1039.
2
Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.贝宁孕期疟疾预防的间歇性治疗：一项比较磺胺多辛-乙胺嘧啶与甲氟喹的随机、开放标签等效性试验。
J Infect Dis. 2009 Sep 15;200(6):991-1001. doi: 10.1086/605474.
3
Treatment of malaria in north-eastern and south-eastern Nigeria: a population study of mefloquine, sulphadoxine, pyrimethamine combination (MSP) vs chloroquine (CQ).尼日利亚东北部和东南部疟疾的治疗：甲氟喹、周效磺胺-乙胺嘧啶合剂（MSP）与氯喹（CQ）的人群研究
West Afr J Med. 2000 Oct-Dec;19(4):293-7.
4
Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.两种不同剂量的甲氟喹加乙胺嘧啶-磺胺多辛与单用乙胺嘧啶-磺胺多辛治疗恶性疟的前瞻性双盲试验。
Bull World Health Organ. 1985;63(4):731-7.
5
Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.尼日利亚恶性疟原虫对甲氟喹-磺胺多辛-乙胺嘧啶和氯喹敏感性的比较。
Afr J Med Med Sci. 1988 Dec;17(4):195-200.
6
Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children.乙胺嘧啶-磺胺多辛与乙胺嘧啶-磺胺多辛加丙磺舒治疗儿童单纯性恶性疟原虫疟疾的开放随机研究
Trop Med Int Health. 2004 May;9(5):606-14. doi: 10.1111/j.1365-3156.2004.01233.x.
7
Review: Intermittent preventive treatment--a new approach to the prevention of malaria in children in areas with seasonal malaria transmission.综述：间歇性预防治疗——季节性疟疾传播地区儿童疟疾预防的新方法。
Trop Med Int Health. 2006 Jul;11(7):983-91. doi: 10.1111/j.1365-3156.2006.01657.x.
8
Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.氯喹与其他抗疟药物的疗效及安全性比较：来自六个非洲国家的荟萃分析
East Afr Med J. 1999 Jun;76(6):314-9.
9
[Mechanisms and dynamics of drug resistance in Plasmodium falciparum].恶性疟原虫耐药性的机制与动态变化
Bull Soc Pathol Exot. 1999 Sep-Oct;92(4):236-41.
10
Efficacy of Sulphadoxine and Pyrimethamine, Doxycycline and their combination in the treatment of chloroquine resistant Falciparum Malaria.周效磺胺与乙胺嘧啶、强力霉素及其联合用药治疗氯喹抗性恶性疟的疗效
Saudi Med J. 2001 Aug;22(8):690-3.

引用本文的文献

1
Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum.新型抗恶性疟原虫化合物WR319691的体内代谢产物表征
Eur J Drug Metab Pharmacokinet. 2011 Sep;36(3):151-8. doi: 10.1007/s13318-011-0047-8. Epub 2011 Jul 13.